Background: This study aimed to evaluate the impact of delayed flap closure on mortality and resource use for treatment of deep sternal wound infection. Methods: The authors analyzed the Truven MarketScan Databases from 2009 to 2013 to identify adult patients who developed deep sternal wound infection after open cardiac surgery and who underwent flap closure for treatment. A multivariable logistic regression model was created to evaluate the relationship between mortality and flap timing. Multivariable Poisson regressions were used to investigate the relationship between flap timing and number of procedures, number of hospitalizations, and length of stay outcomes. A multivariable loglinear regression model was created for cost analysis. All analyses were adjusted for patient risk factors and treatment characteristics. Results: The authors identified 612 patients with deep sternal wound infection who underwent flap closure. The timing of flap closure was delayed more than 7 days after diagnosis in 39 percent of patients. Delayed time to flap closure greater than 3 days after diagnosis of infection was associated with higher mortality odds for delay 4 to 7 days (OR, 2.94) and delay greater than 7 days (OR, 2.75; p < 0.03), greater additional procedures for delay 4 to 7 days (incidence rate ratio, 1.72) and delay greater than 7 days (incidence rate ratio, 1.93; p < 0.001), and up to 43 percent longer hospital length of stay and 37 percent greater costs compared with patients undergoing flap closure 0 to 3 days after diagnosis. Conclusions: Delay in flap closure was associated with greater mortality and resource use. Prompt involvement of reconstructive surgeons may improve quality and efficiency of deep sternal wound infection care. (Plast.
D
eep sternal wound infection is a devastating complication that is estimated to occur in 1 to 3 percent of patients after open cardiac surgery in recent times. [1] [2] [3] [4] [5] [6] [7] [8] Although the incidence of deep sternal wound infection is relatively low, the associated mortality is reported as high as 30 percent, 1, 6, 8 and the complication more than doubles the cost of care. 4, 9, 10 For this reason, recent policy changes have aimed to prevent deep sternal wound infection after cardiac surgery.
Beginning in October of 2008, the Centers for Medicare and Medicaid Services began denying payment for avoidable complications, including mediastinitis after coronary artery bypass graft surgery. 11, 12 The goal of the Centers for Medicare and Medicaid Services policy change is to encourage higher quality inpatient care and ultimately motivate hospitals to take responsibility for potentially preventable complications. Despite these policies, there is concern that the incidence of postoperative infection after cardiac surgery has remained stagnant in recent years. 6, [13] [14] [15] [16] With hospitals assuming greater responsibility for the burdens of deep sternal wound infection, it is imperative to understand the treatment and process variation that exists in managing this complication, with the goal of improving patient outcomes and resource use. Over the past 50 years, the treatment of sternal wound infection has evolved. Although there is not a standardized treatment algorithm for deep sternal wound infection after cardiac surgery, débridement with flap reconstruction has become a widely used method of reconstruction. 17 The use of flaps has reduced the mortality rate from poststernotomy mediastinitis to an estimated 8 to 15 percent. [18] [19] [20] [21] Before widespread use of muscle flap closure, mortality rates were as high as 40 percent. 22, 23 Furthermore, single-stage débridement and flap reconstruction has been shown to have a morbidity and mortality profile comparable to other reconstructive methods in single-center studies. 21, 24 Although several studies have advocated for early débridement 25, 26 and single-stage flap coverage 21, 24, 27 for reconstruction of sternal wounds, little attention has been paid to understand the impact of the time lapse between diagnosis of deep sternal wound infection and flap coverage. Given the low incidence of deep sternal wound infection, a population-level analysis is helpful for investigating the influence of process and treatment variation on patient outcomes at a broad level. The purpose of this study was to evaluate the impact of delayed flap closure on patient outcomes for treatment of deep sternal wound infection using national claims data. We hypothesized that patients undergoing delayed flap closure after deep sternal wound infection would have higher mortality and resource use.
PATIENTS AND METHODS

Data Set and Study Selection
This study received exempt status from the institutional review board. We conducted a retrospective cohort study using the 2009 to 2013 Truven MarketScan Commercial Claims and Encounters and Medicare Supplement/Coordination of Benefits databases to evaluate a sample of patients undergoing flap closure after deep sternal wound infection. The MarketScan databases are composed of a national convenience sample of beneficiaries from large employers, health plans, government, and public organizations. The data set includes inpatient, outpatient, and pharmacy encounters for over 55 million enrollees per year, for the duration of time that individuals are enrolled in the included health plan. 28 Each patient has a unique identifier that facilitates longitudinal evaluation of health care use.
Patients [See Appendix, Supplemental Digital Content 1, which shows the procedure codes and diagnosis codes for patient selection and identification of treatment and risk factors, http://links.lww.com/ PRS/C242.] The full inclusion and exclusion algorithm is outlined in Figure 1 .
Predictor and Outcome Variables
The key predictor variable of interest for this study included the timing of flap reconstruction in days from diagnosis of deep sternal wound infection to the first flap closure. The first inpatient or outpatient health care encounter with a diagnosis of deep sternal wound infection was recorded as the day of diagnosis. Based on the distribution, timing of flap closure was categorized into four categories including same day of deep sternal wound infection diagnosis, 1 to 3 days after diagnosis, 4 to 7 days after diagnosis, and more than 7 days after diagnosis.
The outcomes of interest for the study cohort included in-hospital mortality and 90-day postdeep sternal wound infection diagnosis health care use for patients who were alive and followed in the data set for at least 90 days after diagnosis.
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The 90-day use outcomes included the number of total deep sternal wound infection-related operations, number of infection-related admissions, number of days spent in the hospital, and total costs for deep sternal wound infectionrelated inpatient hospital stays. Current Procedural Terminology codes were used to identify the number of deep sternal wound infection-related operations, which were counted as the total number of trips to the operating room on separate calendar days. Related admissions were identified by examining the primary diagnosis of inpatient services 
Control Variables
In our analyses, we controlled for patient demographic, treatment characteristics, and risk factors to account for additional variables that may impact the outcomes of interest. Patient age at the time of deep sternal wound infection was recorded. We considered treatment characteristics that could impact complexity and health care use related to the index cardiac procedure and deep sternal wound infection treatment, including number of patient comorbidities, length of stay after the initial cardiac surgery, timing of deep sternal wound infection diagnosis, timing of initial débridement, use of negative-pressure therapy, and type of flap reconstruction. Additional post-cardiac surgery complications were recorded, including postoperative sepsis, having an operation for bleeding, and need for a blood transfusion within 7 days of the index procedure. Patient comorbidities were characterized by the Elixhauser Index, 30 which were grouped by number of Elixhauser conditions (zero to two, three to six, and seven or more comorbidities). The timing of diagnosis was defined as days between the most recent cardiac surgery and deep sternal wound infection diagnosis. The El Oakley classification system for timing of mediastinitis was used to define categories for diagnosis timing, with the exception of the El Oakley category of greater than 6 weeks, which was divided into two groups (6 weeks to 3 months, and >3 months). 3 The type of flap reconstruction used was categorized as (1) muscle and/or fascia, (2) omentum flap only, and (3) combined omentum and muscle/fascia flaps.
Statistical Analysis
Multivariable regression models were chosen based on the distribution of each outcome of interest, and controlling for patient risk factors and treatment characteristics. A logistic regression model was created to evaluate the relationship between flap timing and mortality. The number of independent covariates in the mortality model was limited to seven variables based on a recommended maximum 10:1 outcome-topredictor ratio for logistic regression models for sufficient power to predict the outcome of interest. 31 Thus, the variables with the greatest impact on mortality outcomes in bivariate comparisons were included in the final model to not surpass the 10:1 ratio recommendation. Poisson regressions were created to model the impact of flap timing on number of total operations, admissions related to deep sternal wound infection, and total hospital length of stay for deep sternal wound infection-related treatment. Poisson regression models are often used to model count variables, which had the best fit for the models in this study compared with negative binomial regression models. A log-transformed linear regression model, often used for positively skewed outcomes such as cost, was created to model the relationship between flap timing and cost outcomes. For all of the outcome models except for mortality, patients were excluded if they were not alive or enrolled for observation for at least 90 days after diagnosis of deep sternal wound infection. Postestimation marginal effects were calculated for each model to compare adjusted mean outcome predictions among patients in each flap timing group using STATA (version 12; StataCorp LP, College Station, Texas). The postestimation marginal calculation is helpful because it allows comparison of the groups of interest in a measure that is easier to understand compared with odds ratio and incidence rate ratio output from logistic and Poisson regressions, respectively, while still controlling for patient variables in the model. The significance level for statistical analyses was set at p < 0.05.
RESULTS
Among the 1335 patients with deep sternal wound infection who underwent operative treatment, 46 percent (n = 612) underwent flap reconstruction (Fig. 1) . The final cohort of patients undergoing flap reconstruction were observed in the data set for a median of 16 months (interquartile range, 7 to 30 months) before the index cardiac surgery and a median of 14 months (interquartile range, 5 to 28 months) after deep sternal wound infection diagnosis. The median time from index cardiac surgery to deep sternal wound infection diagnosis was 16 days (interquartile range, 3 to 38 days). Muscle or fascia flaps Plastic and Reconstructive Surgery • August 2017 were used in 91 percent of patients (n = 554), whereas omentum-only flaps were used in 4 percent (n = 25) and combined omentum and muscle/fascia flaps were used in 5 percent of patients (n = 33). The timing of flap closure was delayed more than 7 days after deep sternal wound infection diagnosis in 39 percent of patients, and 86 percent underwent flap closure for treatment of deep sternal wound infection during the initial hospitalization in which their cardiac surgery occurred. The remaining sample characteristics, risk factors, and treatment characteristics are outlined in Table 1 .
The incidence of in-hospital mortality was 12 percent (n = 76) in the flap reconstruction cohort. The median time between deep sternal wound infection diagnosis and death in patients who died was 40 days (interquartile range, 12 to 113 days). Unadjusted estimates of the study outcomes based on flap timing groups are outlined in Table 2 . In the multivariable analysis, patients in the delayed flap timing groups had greater odds Table 3 ). The timing of initial débridement and the type of flap used did not have a significant impact on mortality in patients undergoing flap reconstruction. While controlling for independent variables in the model, patients having flap closure 4 to 7 days and more than 7 days after deep sternal wound infection diagnosis had approximately double the predicted probability of death (0.17 and 0.16, respectively) compared with patients undergoing closure the same day as deep sternal wound infection diagnosis and 1 to 3 days after diagnosis (0.08 and 0.07, respectively) (Fig. 2) . Among the other control variables included in the model, an increased length of stay during the index cardiac surgery admission was most strongly related to higher mortality odds (Table 3) .
In the adjusted models evaluating the number of procedures, number of admissions, and total hospital length of stay, delayed flap timing 4 or more days after deep sternal wound infection diagnosis was associated with an increased number of procedures with delay 4 to 7 days after diagnosis (incidence rate ratio, 1.72; 95 percent CI, 1.38 to 2.16) and delay greater than 7 days after diagnosis (incidence rate ratio, 1.93; 95 percent CI, 1.58 to 2.35) and longer hospital length of stay with delay 4 to 7 days (incidence rate ratio, 1.43; CI 1.35 to 1.52) and greater than 7 days after diagnosis (incidence rate ratio, 1.37; 95 percent CI, 1.30 to 1.45). Incidence rate ratios are interpreted as the relative increase in the outcome compared to the reference group. Therefore, patients undergoing flap closure more than 7 days after diagnosis experience a 93 percent increase in number of procedures and a 37 percent increase in length of stay compared with the reference group of patients undergoing flap closure the same day as deep sternal wound infection diagnosis (Table 4 ). Delayed flap timing was not associated with a significant increase in number of admissions. The mean predicted number of procedures ranged from 1.46 procedures in patients with the earliest flap closure to 2.82 procedures in patients with flap closure beyond 1 week after deep sternal wound 
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infection diagnosis (Fig. 3) . Similarly, the range of predicted hospital length of stay ranged from 27 days in patients with the earliest flap closure compared with 38 days in patients in the group with the greatest delay (Fig. 4) . Lastly, patients in the latest flap closure group had nearly $100,000 greater total mean costs for deep sternal wound infection-related care compared with patients in the earliest flap closure group (Table 2 ). In the controlled analysis, delayed flap closure 4 or more days after deep sternal wound infection diagnosis was associated with 37 percent greater costs compared with patients undergoing early flap closure. The relationship between negative-pressure therapy and flap delay is unclear and was likely unreliably captured in the administrative data set. Negative-pressure therapy use was recorded in 17 percent of patients undergoing flap closure. However, in these patients, negative-pressure therapy was associated with a significant increase in the number of procedures (incidence rate ratio, 1.38; 95 percent CI, 1.20 to 1.59), admissions (incidence rate ratio, 1.22; 95 percent CI, 1.01 to 1.47), and prolonged length of hospital stay (incidence rate ratio, 1.20; 95 percent CI, 1.15 to 1.24).
DISCUSSION
Over time, flap reconstruction has become widely used in the treatment of deep sternal wound infection. This population-based cohort study of patients undergoing flap reconstruction after deep sternal wound infection suggests that patients treated with earlier flap coverage had lower mortality and resource use in procedures, hospital days, and costs compared with patients with prolonged time between deep sternal wound infection diagnosis and flap coverage. Although the type of flap used did not impact overall mortality, most patients received muscle or fascia flap reconstruction, with less than 10 percent of patients having reconstruction using an omental flap. Negative-pressure therapy use was captured in only 17 percent of all patients. This low rate of negative-pressure therapy use is likely underestimated because procedures that are not associated with high reimbursement, compared to a more invasive operation, are often unreliably captured in administrative databases. However, rates of negative-pressure therapy use were highest in the groups with the greatest flap delay, and negative-pressure therapy was associated with higher resource use in the adjusted analyses. Given the recent policy change by the Centers for Medicare and Medicaid Services to designate deep sternal wound infection as a preventable hospital-acquired condition, providers and hospitals must be proactive in identifying processes of care that contribute to inefficient use of resources. It is unclear whether the decreased mortality associated with early flap closure is because of the physiologic benefits of prompt flap closure, or whether facilities that are more aggressive with plastic surgeon consultation and early flap closure are better at managing deep sternal wound infection as a whole, which then leads to decreased mortality. The current study is unable to answer this question, but we hypothesize that the latter phenomenon is the likely explanation.
Timely surgical intervention has been associated with decreased resource use among several surgical conditions, including sternal wound infection, lower extremity trauma, and hip fractures. 25, 32, 33 In a previous study of 1335 patients who underwent various surgical treatments for deep sternal wound infection, we demonstrated the important association between early excisional débridement, decreased hospital days, and lower number of admissions. 25 Delayed initial débridement timing was not associated with increased mortality in the previous cohort of patients having any surgical treatment for deep sternal wound infection or in the current study of flap closure patients. However, delay of flap treatment was directly related to both increased mortality odds and increased resource use outcomes in the present study. This finding may argue against the likelihood that patients with flap delay are sicker and therefore have increased mortality. If patient stability were the sole cause of delayed flap reconstruction and increased mortality, we would expect to see a similar relationship between delayed initial excisional débridement and higher mortality. However, this was not the case. 
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Previous single-center studies have advocated for immediate single-stage flap reconstruction in patients with deep sternal wound infection. 21, 24 In line with our findings, Cabbabe and Cabbabe found that early débridement and bilateral pectoralis muscle flap reconstruction demonstrated a significant decrease in morbidity, mortality, and length of stay compared with patients with delayed reconstruction. 24 However, many patients in the early treatment group in the study by Cabbabe and Cabbabe underwent reconstruction within 5 to 10 days of diagnosis of deep sternal wound infection, often with referral to the plastic surgeon within 4 days of diagnosis. The findings of the current study suggest that mortality and resource use vary even within the first week of deep sternal wound infection diagnosis and that patients may benefit from plastic surgery consultation and reconstruction as early as possible.
The current study has limitations inherent in any administrative data study. First, clinical information such as wound severity, size, and the number of excisional débridements needed before flap closure cannot be captured in the data set. However, we would not expect these traits to be different between the flap timing groups. In addition, clinical factors that may increase complications related to the original cardiac surgery and risk for developing infection, such as timing of antibiotic administration, thermoregulation, or glycemic control are not available. However, we captured the general complexity of cardiac surgery and deep sternal wound infection with creation of variables such as postoperative sepsis, reoperation for bleeding/need for transfusion, and hospital length of stay after the index cardiac surgery. These variables are validated in the models by demonstrating an expected increase in mortality and resource use. Furthermore, we cannot identify reasons for flap delay using this database, which could be systems-related or attributable to the medical stability of the patient. However, we used the initial operative débridement timing as a control variable to account for patients who started with delay of their initial surgical treatment to account for patients who may have been unstable for an early initial débridement. We hypothesize that some component of delay is related to provider or facility-level attributes, but these considerations were unable to be studied because of limitations of the data set in not containing provider or facility variables. Lastly, the data set does not capture uninsured patients and information about patient socioeconomic status, which may impact timing of treatment after deep sternal wound infection and patient outcomes.
Despite these limitations, this study highlights the relationship between flap reconstruction delay and increased mortality and resource use. Given this relationship, there is a need to prospectively study flap timing in relation to important markers of clinical severity of sepsis and the wound conditions. Furthermore, comparative evaluation of patient outcomes between institutions with varying timing of closure would highlight the impact of systems-based factors. Providers must be cognizant of the potential impact of treatment variation on the quality of deep sternal wound infection care. With greater financial burdens placed on hospitals because of the lack of reimbursement for treatment of deep sternal wound infection and bundled payment initiatives on the horizon, providers and health systems must seek to identify modifiable systems factors that lead to inefficient surgical care. Prompt involvement of reconstructive surgeons at the time of deep sternal wound infection diagnosis is one step that health systems may consider to reduce systems-based delays, with the potential of improving patient outcomes and resource use. 
